Trials / Completed
CompletedNCT04083547
Circulating Tumour Cells in Patients With Peritoneal Metastases
Cirkulerande Tumörceller Hos Patienter Med Bukhinnespridda tumörer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 114 (actual)
- Sponsor
- Uppsala University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.
Detailed description
CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | iCellate | New method of circulating tumour cell detection and capture. |
Timeline
- Start date
- 2017-10-17
- Primary completion
- 2019-10-01
- Completion
- 2020-11-01
- First posted
- 2019-09-10
- Last updated
- 2020-11-04
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04083547. Inclusion in this directory is not an endorsement.